30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Bluejay Diagnostics Inc (BJDX)

Track

The most recent insider trading activity occurred on March 14, 2026, with multiple executives, including the President and CEO, making significant buy transactions totaling $125,000. Prior to this, smaller buy transactions were noted in December 2023. The bulk of the recorded insider buying activity took place in 2022.
Stock chart
Ticker: BJDX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
CHASE DONALD R
1 purchase — total 25,000 USD
Buy 14 Mar 2026
Value US$2,686,704.27 | Price 122.62 | Shares 56,593
Buy 14 Mar 2026
Value US$903,548.23 | Price 129.61 | Shares 23,610
Buy 14 Mar 2026
Value US$25,000.00 | Price 2.00 | Shares 12,500
Buy 14 Mar 2026
Value US$25,000.00 | Price 2.00 | Shares 12,500
Buy 14 Mar 2026
Value US$25,000.00 | Price 2.00 | Shares 12,500
Buy 13 Dec 2023
Value US$1,535.00 | Price 3.07 | Shares 500
Buy 13 Dec 2023
Value US$1,635.00 | Price 3.27 | Shares 500
Buy 26 Aug 2022
Value US$20,600.00 | Price 1.03 | Shares 20,000
Buy 25 Apr 2022
Value US$19,800.00 | Price 0.99 | Shares 20,000
Buy 17 Mar 2022
Value US$11,830.00 | Price 1.18 | Shares 10,000
Buy 17 Mar 2022
Value US$2,897.50 | Price 1.16 | Shares 2,500
Buy 17 Mar 2022
Value US$47,120.00 | Price 1.18 | Shares 40,000
Buy 16 Mar 2022
Value US$65,400.00 | Price 1.09 | Shares 60,000
Buy 16 Mar 2022
Value US$5,100.00 | Price 1.02 | Shares 5,000
Buy 15 Mar 2022
Value US$455.00 | Price 0.91 | Shares 500
Buy 14 Mar 2022
Value US$9,975.00 | Price 0.95 | Shares 10,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-18 2026-03-14 B Purchase
CHASE DONALD R
Non-Executive Director
56,593 -41.8%
122.62
US$2,686,704 		56,593 -41.8% 122.62 US$2,686,704
2026-05-18 2026-03-14 B Purchase
2.4
Wurth Douglas Clark
Non-Executive Director
23,610 -44.3%
129.61
US$903,548 		23,610 -44.3% 129.61 US$903,548
2026-05-18 2026-03-14 B Purchase
1.8
Dey Indranil

President and CEO

Executive Director
16,280 -0.6%
210.23
US$1,112,847 		16,280 -0.6% 210.23 US$1,112,847
2026-05-18 2026-03-14 B Purchase
2.2
Dey Svetlana
Non-Executive Director
12,500 +1250000.0%
2.00
US$25,000 		12,500 +1250000.0% 2.00 US$25,000
2026-05-18 2026-03-14 B Purchase
ZEIDMAN FRED S
Non-Executive Director
12,500 +inf%
2.00
US$25,000 		12,500 +inf% 2.00 US$25,000
2023-12-14 2023-12-13 B Purchase
2.2
Dey Svetlana
Non-Executive Director
500 +50.0%
3.07
US$1,535 		500 +50.0% 3.07 US$1,535
2023-12-14 2023-12-13 B Purchase
1.8
Dey Indranil

President and CEO

Executive Director Large shareholder
500 +1.8%
3.27
US$1,635 		500 +1.8% 3.27 US$1,635
2022-09-07 2022-08-26 B Purchase
3.0
Fisher Kenneth R

Chief Financial Officer

Officer
20,000 +100.0%
1.03
US$20,600 		20,000 +100.0% 1.03 US$20,600
2022-04-27 2022-04-25 B Purchase
3.0
Fisher Kenneth R

Chief Financial Officer

Officer
20,000 +inf%
0.99
US$19,800 		20,000 +inf% 0.99 US$19,800
2022-03-21 2022-03-17 B Purchase
2.2
Dey Svetlana
Non-Executive Director Large shareholder
10,000 +inf%
1.18
US$11,830 		10,000 +inf% 1.18 US$11,830
2022-03-21 2022-03-17 B Purchase
2.9
Kinder Gordon Winston

Chief Financial Officer

Officer
2,500 +15.6%
1.16
US$2,898 		2,500 +15.6% 1.16 US$2,898
2022-03-18 2022-03-17 B Purchase
2.4
Wurth Douglas Clark
Non-Executive Director Large shareholder
40,000 +1.8%
1.18
US$47,120 		40,000 +1.8% 1.18 US$47,120
2022-03-17 2022-03-16 B Purchase
2.4
Wurth Douglas Clark
Non-Executive Director Large shareholder
60,000 +2.7%
1.09
US$65,400 		60,000 +2.7% 1.09 US$65,400
2022-03-16 2022-03-16 B Purchase
2.9
Kinder Gordon Winston

Chief Financial Officer

Officer
5,000 +45.5%
1.02
US$5,100 		5,000 +45.5% 1.02 US$5,100
2022-03-16 2022-03-15 B Purchase
2.9
Kinder Gordon Winston

Chief Financial Officer

Officer
500 +4.8%
0.91
US$455 		500 +4.8% 0.91 US$455
2022-03-16 2022-03-14 B Purchase
2.9
Kinder Gordon Winston

Chief Financial Officer

Officer
10,500 +inf%
0.95
US$9,975 		10,500 +inf% 0.95 US$9,975
Explore more

More insider trading research around Bluejay Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America